BR9300469A - Composto,formulacao farmaceutica e processo para a preparacao do composto - Google Patents

Composto,formulacao farmaceutica e processo para a preparacao do composto

Info

Publication number
BR9300469A
BR9300469A BR9300469A BR9300469A BR9300469A BR 9300469 A BR9300469 A BR 9300469A BR 9300469 A BR9300469 A BR 9300469A BR 9300469 A BR9300469 A BR 9300469A BR 9300469 A BR9300469 A BR 9300469A
Authority
BR
Brazil
Prior art keywords
compound
preparation
pharmaceutical formulation
provides
dihydrobenzofuran
Prior art date
Application number
BR9300469A
Other languages
English (en)
Inventor
George Bernard Boder
William Joseph Ehlhardt
Gerald Burr Grindey
John Eldon Toth
John Frederick Worzalla
John Lyle Zimmermann
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9300469A publication Critical patent/BR9300469A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Undergarments, Swaddling Clothes, Handkerchiefs Or Underwear Materials (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR9300469A 1992-02-05 1993-02-03 Composto,formulacao farmaceutica e processo para a preparacao do composto BR9300469A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/831,604 US5254582A (en) 1992-02-05 1992-02-05 Antitumor compositions and methods

Publications (1)

Publication Number Publication Date
BR9300469A true BR9300469A (pt) 1993-08-10

Family

ID=25259448

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9300469A BR9300469A (pt) 1992-02-05 1993-02-03 Composto,formulacao farmaceutica e processo para a preparacao do composto

Country Status (25)

Country Link
US (1) US5254582A (pt)
EP (1) EP0555036B1 (pt)
JP (1) JP3210117B2 (pt)
KR (1) KR100246148B1 (pt)
CN (1) CN1044239C (pt)
AT (1) ATE170853T1 (pt)
AU (1) AU658043B2 (pt)
BR (1) BR9300469A (pt)
CA (1) CA2088719A1 (pt)
CY (1) CY2101B1 (pt)
CZ (1) CZ282753B6 (pt)
DE (1) DE69320844T2 (pt)
DK (1) DK0555036T3 (pt)
ES (1) ES2121940T3 (pt)
FI (1) FI930453A (pt)
HU (2) HU213231B (pt)
IL (1) IL104574A (pt)
MX (1) MX9300558A (pt)
MY (1) MY109640A (pt)
NO (1) NO302472B1 (pt)
NZ (1) NZ245818A (pt)
RU (1) RU2072996C1 (pt)
SG (1) SG79181A1 (pt)
YU (1) YU48915B (pt)
ZA (1) ZA93689B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
US5529999A (en) * 1994-03-04 1996-06-25 Eli Lilly And Company Antitumor compositions and methods of treatment
DE69708340T2 (de) * 1996-08-22 2002-05-16 Dong Wha Pharm Ind Co Ltd Arylsulfonylimidazolon-derivate als antitumormittel
EP0929540A4 (en) * 1996-10-04 2001-12-12 Lilly Co Eli ANTI-TUMOR COMPOSITIONS AND THERAPEUTIC METHODS
US6281240B1 (en) * 1997-04-10 2001-08-28 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US5932407A (en) * 1997-04-30 1999-08-03 Eastman Kodak Company Color photographic element containing oxidized developer-scavenging naphtholic coupler forming wash-out dye
CL2004001834A1 (es) 2003-07-23 2005-06-03 Bayer Pharmaceuticals Corp Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
WO2006030941A1 (ja) * 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. スルホンアミド含有化合物の血管新生阻害物質との併用
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
JPWO2007123274A1 (ja) 2006-04-20 2009-09-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド化合物の新規感受性マーカー
CN104941647B (zh) * 2015-06-18 2017-07-04 四川之江高新材料股份有限公司 合成n‑甲基吗啉的方法及所用的负载型催化剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3083207A (en) * 1963-03-26 Indolinesulfonylureas
US1208561A (en) * 1914-09-14 1916-12-12 Stephen E Huff Sound-box attachment for phonographs.
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
US3102121A (en) * 1961-06-29 1963-08-27 Olin Mathieson Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas
GB1050447A (pt) * 1962-04-11
US3849110A (en) * 1963-01-07 1974-11-19 Lilly Co Eli Herbicidal method employing aryl-sulfonylureas or salts thereof
US3736122A (en) * 1969-04-10 1973-05-29 C Tung Method of controlling plant growth
AU1862083A (en) * 1982-09-02 1984-03-08 Duphar International Research B.V. Tumor growth inhibitors
CA1208561A (en) * 1984-01-19 1986-07-29 Marius S. Brouwer Pharmaceutical compositions containing benzoylurea compounds
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
JPS6163671A (ja) * 1984-09-05 1986-04-01 Shionogi & Co Ltd ２，３−ジヒドロベンゾフラン−５−スルホンアミド誘導体および降圧利尿剤
IL80032A (en) * 1985-09-23 1992-07-15 Lilly Co Eli Anti-tumor phenyl-aminocarbonylsulfonamides,their preparation and pharmaceutical compositions containing them
US5116874A (en) * 1985-09-23 1992-05-26 Eli Lilly And Company Anti-tumor method and compounds
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
IL98784A0 (en) * 1990-07-17 1992-07-15 Lilly Co Eli Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment

Also Published As

Publication number Publication date
CZ282753B6 (cs) 1997-09-17
IL104574A (en) 1997-02-18
AU658043B2 (en) 1995-03-30
ES2121940T3 (es) 1998-12-16
EP0555036B1 (en) 1998-09-09
RU2072996C1 (ru) 1997-02-10
CN1044239C (zh) 1999-07-21
DE69320844T2 (de) 1999-03-04
ATE170853T1 (de) 1998-09-15
MX9300558A (es) 1993-08-01
ZA93689B (en) 1994-08-01
KR930017885A (ko) 1993-09-20
CZ12093A3 (en) 1993-12-15
EP0555036A3 (en) 1993-11-24
FI930453A0 (fi) 1993-02-02
IL104574A0 (en) 1993-06-10
HU213231B (en) 1997-03-28
NZ245818A (en) 1995-03-28
DE69320844D1 (de) 1998-10-15
HUT63842A (en) 1993-10-28
MY109640A (en) 1997-03-31
CA2088719A1 (en) 1993-08-06
DK0555036T3 (da) 1999-06-07
US5254582A (en) 1993-10-19
JPH05306277A (ja) 1993-11-19
AU3218393A (en) 1993-08-12
SG79181A1 (en) 2001-03-20
HU211561A9 (en) 1995-12-28
FI930453A (fi) 1993-08-06
NO930380L (no) 1993-08-06
YU48915B (sh) 2002-11-15
CY2101B1 (en) 2002-04-05
EP0555036A2 (en) 1993-08-11
NO930380D0 (no) 1993-02-03
HU9300288D0 (en) 1993-04-28
JP3210117B2 (ja) 2001-09-17
NO302472B1 (no) 1998-03-09
KR100246148B1 (ko) 2000-04-01
YU5893A (sh) 1996-07-24
CN1075961A (zh) 1993-09-08

Similar Documents

Publication Publication Date Title
MA26449A1 (fr) Derives d'acides amines .
MC2040A1 (fr) Derives d'acides amines
MA22014A1 (fr) Derives d'acides amines .
MC2151A1 (fr) Derives d'acides amines
MC2022A1 (fr) Derives d'acides amines
BR9300469A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
RU93004535A (ru) Соединения, способ получения и фармацевтическая композиция на их основе
MC2107A1 (fr) Derives d'acides amines
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
CA2135710A1 (en) Melatonin derivatives for use in treating desynchronization disorders
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
SE9302218D0 (sv) New use
ITMI910658A0 (it) N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari
ITRM940322A0 (it) "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
BR9713044A (pt) Composto, uso de um composto, processo para sua preparação,e, formulação farmacêutica.
CA2251060A1 (en) Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action
GB9308111D0 (en) Active compound from a stonge
TH9193B (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
TH13149A (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
TH13149EX (th) สารผสมต่อต้านเนื้องอกและวิธีของการรักษา
MX9203096A (es) Derivados de n-(2'-aminofenil)-benzamida, proceso para la preparacion de la misma y composiciones farmaceuticas que los contienen.
IT1254191B (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina

Legal Events

Date Code Title Description
EE Request for examination
FA Application withdrawn